A detailed history of Flavin Financial Services, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Flavin Financial Services, Inc. holds 3,611 shares of AMGN stock, worth $1.02 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares
3,611
Previous 3,269 10.46%
Holding current value
$1.02 Million
Previous $852 Million 32.04%
% of portfolio
1.03%
Previous 0.81%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 23, 2025

BUY
$258.59 - $327.36 $88,437 - $111,957
342 Added 10.46%
3,611 $1.13 Billion
Q4 2024

Jan 24, 2025

BUY
$258.78 - $328.31 $845,951 - $1.07 Million
3,269 New
3,269 $852 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $151B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Flavin Financial Services, Inc. Portfolio

Follow Flavin Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flavin Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Flavin Financial Services, Inc. with notifications on news.